Inactive Instrument

News Rafarma Pharmaceuticals, Inc. Other OTC

Equities

RAFA

US75062C1009

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University	12-11	AQ
Rafarma Pharmaceutical news update	11-30	AQ
Rafarma Pharmaceuticals : RAFA Financials Q2	22-08-15	PU
Rafarma Pharmaceuticals strengthens its position in Central Asia	22-04-29	AQ
Rafarma’s Slavich Noya Technology Division Expands Printing Production	22-02-07	AQ
RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear Research	21-12-21	AQ
RAFA To Add Major Component to the Tashkent Pharma Park	21-12-17	AQ
RafarmaPharmaceuticals, Inc. to Add Major Component to the Tashkent Pharma Park	21-12-17	CI
Explosive Growth Launches Kraspharma Into REMEDIUM TOP-5	21-11-19	AQ
Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs	21-08-19	GL
Letter to Shareholders from the Chairman of the Board Ilya Shpurov	21-08-10	GL
Rafarma Signs Trilateral Investment Agreement Officially Launching Tashkent Pharmaceutical Plant Build	21-07-30	GL
Rafarma’s Global Pharmaceutical Strategy At A Glance	21-05-18	GL
Rafarma To Expand Proton Therapy Centers	21-05-07	GL
Rafarma Pharmaceuticals, Inc. to Expand Proton Therapy Centers	21-05-07	CI
Rafarma and Haifa Technopark Enter Talks for Joint Venture	21-04-30	GL
Rafarma Embarks on Aggressive Global Partnerships Plan	21-03-04	GL
Rafarma Secures Joint Venture Agreement with the Pharmaceutical Industry Development Agency of Uzbekistan	21-01-29	GL
Rafarma Pharmaceuticals, Inc. Secures Joint Venture Agreement with the Pharmaceutical Industry Development Agency of Uzbekistan	21-01-29	CI
Vaccines Lab Sdn Bhd Enters Master Strategic Joint Venture Agreement with Rafarma Pharmaceuticals Inc	20-12-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Rafarma Pharmaceuticals, Inc. Other OTC

Equities

RAFA

US75062C1009

Summary

Filters